Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
+1.31M
-
Total reported value, excl. options
-
$98.6M
-
Value change
-
+$6.35M
-
Put/Call ratio
-
1.86
-
Number of buys
-
38
-
Number of sells
-
-27
-
Price
-
$4.50
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q4 2015
93 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q4 2015.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
of 52.3M outstanding shares and own 41.93% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.22M shares), First Light Asset Management, LLC (2.29M shares), DIMENSIONAL FUND ADVISORS LP (1.53M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.39M shares), VANGUARD GROUP INC (1.27M shares), RENAISSANCE TECHNOLOGIES LLC (1.25M shares), BlackRock Institutional Trust Company, N.A. (1.24M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.13M shares), UBS ASSET MANAGEMENT AMERICAS INC (666K shares), and Lone Star Value Management LLC (600K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.